Curr Neurol Neurosci Rep
September 2024
Purpose Of Review: The current review aims to provide an overview of migraine treatment strategies in medically complex patients, including those with renal, liver, and cardiovascular disease.
Recent Findings: In cardiovascular disease, gepants are likely safe for acute therapy; NSAIDs, ergotamines, and triptans are not recommended. Beta-blockers, ACEi/ARBs, and verapamil have potential cardiovascular benefits in addition to migraine preventive benefit.
J Labelled Comp Radiopharm
February 2024
Primary aldosteronism (PA) is the leading secondary cause of hypertension. Determining whether one (unilateral) or both (bilateral) adrenal glands are the source of PA in a patient remains challenging, and yet it is a critical step in the decision whether to recommend potentially curative surgery (adrenalectomy) or lifelong medical therapy (typically requiring multiple drugs). Recently, we have developed a fluorine-18 radiopharmaceutical [ F]CETO to permit greater access to PA molecular imaging.
View Article and Find Full Text PDFCurr Neurol Neurosci Rep
July 2023
Overview: Medication overuse headache (MOH) is highly prevalent among individuals with primary headache disorders.
Purpose Of Review: (1) Provide an update on epidemiology, risk factors, and treatment strategies of MOH and (2) provide recommendations on the management of MOH.
Recent Findings: The prevalence of MOH ranges from 0.